Skip to Main Content

Author Details

Roya Navab
Princess Margaret Cancer Centre, University Health Network
1997
42
23
PMIDPaper TitleJournal TitlePublished Year
36535627Single-Cell Analysis Reveals Transcriptomic Features of Drug-Tolerant Persisters and Stromal Adaptation in a Patient-Derived EGFR-Mutated Lung Adenocarcinoma Xenograft Model.J Thorac Oncol2023
36651498Wide-field Stokes polarimetric microscopy for second harmonic generation imaging.J Biophotonics2023
36233024Collagen Type XI Inhibits Lung Cancer-Associated Fibroblast Functions and Restrains the Integrin Binding Site Availability on Collagen Type I Matrix.Int J Mol Sci2022
35378690Integrin α11β1 in tumor fibrosis: more than just another cancer-associated fibroblast biomarker?J Cell Commun Signal2022
36456811Unsupervised determination of lung tumor margin with widefield polarimetric second-harmonic generation microscopy.Sci Rep2022
35008369Tumor-Associated Regulatory T Cell Expression of LAIR2 Is Prognostic in Lung Adenocarcinoma.Cancers (Basel)2021
32341852Polarimetric second-harmonic generation microscopy of the hierarchical structure of collagen in stage I-III non-small cell lung carcinoma.Biomed Opt Express2020
30978569Characterization of Distinct Populations of Carcinoma-Associated Fibroblasts from Non-Small Cell Lung Carcinoma Reveals a Role for ST8SIA2 in Cancer Cell Invasion.Neoplasia2019
31330989Somatic Alteration Burden Involving Non-Cancer Genes Predicts Prognosis in Early-Stage Non-Small Cell Lung Cancer.Cancers (Basel)2019
31121900LOXL1 Is Regulated by Integrin α11 and Promotes Non-Small Cell Lung Cancer Tumorigenicity.Cancers (Basel)2019
29661164Helicase-like transcription factor expression is associated with a poor prognosis in Non-Small-Cell Lung Cancer (NSCLC).BMC Cancer2018
27678171Senescent Carcinoma-Associated Fibroblasts Upregulate IL8 to Enhance Prometastatic Phenotypes.Mol Cancer Res2017
26148229Integrin α11β1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer.Oncogene2016
26376999An orally administered DNA vaccine targeting vascular endothelial growth factor receptor-3 inhibits lung carcinoma growth.Tumour Biol2016
24989599A role for matrix remodelling proteins in invasive and malignant meningiomas.Neuropathol Appl Neurobiol2015
25826681Appropriateness of using patient-derived xenograft models for pharmacologic evaluation of novel therapies for esophageal/gastro-esophageal junction cancers.PLoS One2015
25381825Coiled-coil domain containing 68 (CCDC68) demonstrates a tumor-suppressive role in pancreatic ductal adenocarcinoma.Oncogene2015
24465899p120RasGAP is a mediator of rho pathway activation and tumorigenicity in the DLD1 colorectal cancer cell line.PLoS One2014
25360372Characterization of collagen in non-small cell lung carcinoma with second harmonic polarization microscopy.Biomed Opt Express2014
25084400MicroRNA-21 (miR-21) regulates cellular proliferation, invasion, migration, and apoptosis by targeting PTEN, RECK and Bcl-2 in lung squamous carcinoma, Gejiu City, China.PLoS One2014
23526597Molecular biology of normal melanocytes and melanoma cells.J Clin Pathol2013
22307136L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.Clin Cancer Res2012
21474781Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer.Proc Natl Acad Sci U S A2011
21609022Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer.J Proteome Res2011
20936153From melanocyte to metastatic malignant melanoma.Dermatol Res Pract2010
19093877Photodynamic molecular beacon triggered by fibroblast activation protein on cancer-associated fibroblasts for diagnosis and treatment of epithelial cancers.J Med Chem2009
20019837Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells.Neoplasia2009
19458065Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts.Cancer Res2009
18192688Gab1 but not Grb2 mediates tumor progression in Met overexpressing colorectal cancer cells.Carcinogenesis2008
18469859Loss of responsiveness to IGF-I in cells with reduced cathepsin L expression levels.Oncogene2008
17600088Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells.Proc Natl Acad Sci U S A2007
17951403Abelson interactor protein-1 positively regulates breast cancer cell proliferation, migration, and invasion.Mol Cancer Res2007
15944448A complementation method for functional analysis of mammalian genes.Nucleic Acids Res2005
15247903Modeling of lung cancer by an orthotopically growing H460SM variant cell line reveals novel candidate genes for systemic metastasis.Oncogene2004
15901415PADMA-28, a traditional Tibetan herbal preparation, blocks cellular responses to bFGF and IGF-I.Inflammopharmacology2004
15289311Expression of chicken ovalbumin upstream promoter-transcription factor II enhances invasiveness of human lung carcinoma cells.Cancer Res2004
12204889Regulation of human Clara cell 10 kD protein expression by chicken ovalbumin upstream promoter transcription factors (COUP-TFs).Am J Respir Cell Mol Biol2002
11278993Inhibition of endosomal insulin-like growth factor-I processing by cysteine proteinase inhibitors blocks receptor-mediated functions.J Biol Chem2001
11007947Inhibition of the type I insulin-like growth factor receptor expression and signaling: novel strategies for antimetastatic therapy.Biochem Pharmacol2000
9699649Regulation of the Mr 72,000 type IV collagenase by the type I insulin-like growth factor receptor.Cancer Res1998
9062388Inhibition of carcinoma cell invasion and liver metastases formation by the cysteine proteinase inhibitor E-64.Clin Exp Metastasis1997
9194570Suppression of basement membrane type IV collagen degradation and cell invasion in human melanoma cells expressing an antisense RNA for MMP-1.Biochim Biophys Acta1997
  • 1 - 42 of 42

Recommended Authors

University of North Carolina at Chapel Hill
Career Start Year 2009
Number of shared co-authors 3
Medical College, Yan'an University
Career Start Year 2007
Number of shared co-authors 2
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 3
College of Life Science, CHA University
Career Start Year 2003
Number of shared co-authors 0
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 0
Research Institute, National Cancer Center
Career Start Year 2000
Number of shared co-authors 0
David Geffen School of Medicine at University of California at Los Angeles
Career Start Year 1999
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Uppsala University
Career Start Year 1997
Number of shared co-authors 0
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center
Career Start Year 1994
Number of shared co-authors 1
Oncode Institute
Career Start Year 1993
Number of shared co-authors 0
The South China University of Technology Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 1
Candiolo Cancer Institute - FPO IRCCS
Career Start Year 1993
Number of shared co-authors 0
Virginia Commonwealth University
Career Start Year 1993
Number of shared co-authors 1
University of South Carolina
Career Start Year 1993
Number of shared co-authors 0
University of Chicago
Career Start Year 1993
Number of shared co-authors 0
Oklahoma Medical Research Foundation
Career Start Year 1992
Number of shared co-authors 0
Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
Career Start Year 1992
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 1
Research Institute in Oncology and Hematology
Career Start Year 1991
Number of shared co-authors 1
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Career Start Year 1989
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 3
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year 1988
Number of shared co-authors 0
Netherlands Cancer Institute
Career Start Year 1987
Number of shared co-authors 0
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 2
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 0
University of California, USA Cardiovascular Research Institute san francisco
Career Start Year 1981
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 2

Collaborators

University Health Network, University of Toronto
Co-authored papers 27
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 12
Princess Margaret Hospital, University of Toronto
Co-authored papers 8
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
Schroeder Arthritis Institute
Co-authored papers 5
University Health Network, Princess Margaret Cancer Centre
Co-authored papers 5
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
Co-authored papers 4
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
The Princess Margaret Cancer Centre/University of Toronto
Co-authored papers 3
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Co-authored papers 3
Sheffield Institute of Translational Neuroscience, University of Sheffield
Co-authored papers 3
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
University of Toronto
Co-authored papers 2
Hospital for Sick Children, University of Toronto
Co-authored papers 2
Hospital for Sick Children
Co-authored papers 2
Dalhousie University
Co-authored papers 2
Toronto General Research Institute, University Health Network
Co-authored papers 2
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Princess Margaret Cancer Centre
Co-authored papers 1
University of Toronto, University Health Network
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
Toronto General Hospital
Co-authored papers 1
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Co-authored papers 1
The First Hospital of Lanzhou University
Co-authored papers 1
2Ontario Institute for Cancer Research
Co-authored papers 1
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 1